Cargando…

Balneotherapy for Fibromyalgia Syndrome: A Systematic Review and Meta-Analysis

(1) Background: The efficiency of balneotherapy (BT) for fibromyalgia syndrome (FMS) remains elusive. (2) Methods: Cochrane Library, EMBASE, MEDLINE, PubMed, Clinicaltrials.gov, and PsycINFO were searched from inception to 31 May 2020. Randomized controlled trials (RCTs) with at least one indicator...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Chun-Feng, Ma, Kun-Long, Li, Qian-Lu, Luan, Fu-Jun, Wang, Qun-Bo, Zhang, Ming-Hua, Viswanath, Omar, Myrcik, Dariusz, Varrassi, Giustino, Wang, Hai-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038322/
https://www.ncbi.nlm.nih.gov/pubmed/33916744
http://dx.doi.org/10.3390/jcm10071493
_version_ 1783677348446470144
author Cao, Chun-Feng
Ma, Kun-Long
Li, Qian-Lu
Luan, Fu-Jun
Wang, Qun-Bo
Zhang, Ming-Hua
Viswanath, Omar
Myrcik, Dariusz
Varrassi, Giustino
Wang, Hai-Qiang
author_facet Cao, Chun-Feng
Ma, Kun-Long
Li, Qian-Lu
Luan, Fu-Jun
Wang, Qun-Bo
Zhang, Ming-Hua
Viswanath, Omar
Myrcik, Dariusz
Varrassi, Giustino
Wang, Hai-Qiang
author_sort Cao, Chun-Feng
collection PubMed
description (1) Background: The efficiency of balneotherapy (BT) for fibromyalgia syndrome (FMS) remains elusive. (2) Methods: Cochrane Library, EMBASE, MEDLINE, PubMed, Clinicaltrials.gov, and PsycINFO were searched from inception to 31 May 2020. Randomized controlled trials (RCTs) with at least one indicator were included, i.e., pain, Fibromyalgia Impact Questionnaire (FIQ), Tender Points Count (TPC), and Beck’s Depression Index (BDI). The outcome was reported as a standardized mean difference (SMD), 95% confidence intervals (CIs), and I(2) for heterogeneity at three observational time points. GRADE was used to evaluate the strength of evidence. (3) Results: Amongst 884 citations, 11 RCTs were included (n = 672). Various BT regimens were reported (water types, duration, temperature, and ingredients). BT can benefit FMS with statistically significant improvement at different time points (pain of two weeks, three and six months: SMD = −0.92, −0.45, −0.70; 95% CI (−1.31 to −0.53, −0.73 to −0.16, −1.34 to −0.05); I(2) = 54%, 51%, 87%; GRADE: very low, moderate, low; FIQ: SMD = −1.04, −0.64, −0.94; 95% CI (−1.51 to −0.57, −0.95 to −0.33, −1.55 to −0.34); I(2) = 76%, 62%, 85%; GRADE: low, low, very low; TPC at two weeks and three months: SMD = −0.94, −0.47; 95% CI (−1.69 to −0.18, −0.71 to −0.22); I(2) = 81%, 0; GRADE: very low, moderate; BDI at six months: SMD = −0.45; 95% CI (−0.73 to −0.17); I(2) = 0; GRADE: moderate). There was no statistically significant effect for the TPC and BDI at the remaining time points (TPC at six months: SMD = −0.89; 95% CI (−1.85 to 0.07); I(2) = 91%; GRADE: very low; BDI at two weeks and three months: SMD = −0.35, −0.23; 95% CI (−0.73 to 0.04, −0.64 to 0.17); I(2) = 24%, 60%; GRADE: moderate, low). (4) Conclusions: Very low to moderate evidence indicates that BT can benefit FMS in pain and quality-of-life improvement, whereas tenderness and depression improvement varies at time phases. Established BT regimens with a large sample size and longer observation are needed.
format Online
Article
Text
id pubmed-8038322
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80383222021-04-12 Balneotherapy for Fibromyalgia Syndrome: A Systematic Review and Meta-Analysis Cao, Chun-Feng Ma, Kun-Long Li, Qian-Lu Luan, Fu-Jun Wang, Qun-Bo Zhang, Ming-Hua Viswanath, Omar Myrcik, Dariusz Varrassi, Giustino Wang, Hai-Qiang J Clin Med Review (1) Background: The efficiency of balneotherapy (BT) for fibromyalgia syndrome (FMS) remains elusive. (2) Methods: Cochrane Library, EMBASE, MEDLINE, PubMed, Clinicaltrials.gov, and PsycINFO were searched from inception to 31 May 2020. Randomized controlled trials (RCTs) with at least one indicator were included, i.e., pain, Fibromyalgia Impact Questionnaire (FIQ), Tender Points Count (TPC), and Beck’s Depression Index (BDI). The outcome was reported as a standardized mean difference (SMD), 95% confidence intervals (CIs), and I(2) for heterogeneity at three observational time points. GRADE was used to evaluate the strength of evidence. (3) Results: Amongst 884 citations, 11 RCTs were included (n = 672). Various BT regimens were reported (water types, duration, temperature, and ingredients). BT can benefit FMS with statistically significant improvement at different time points (pain of two weeks, three and six months: SMD = −0.92, −0.45, −0.70; 95% CI (−1.31 to −0.53, −0.73 to −0.16, −1.34 to −0.05); I(2) = 54%, 51%, 87%; GRADE: very low, moderate, low; FIQ: SMD = −1.04, −0.64, −0.94; 95% CI (−1.51 to −0.57, −0.95 to −0.33, −1.55 to −0.34); I(2) = 76%, 62%, 85%; GRADE: low, low, very low; TPC at two weeks and three months: SMD = −0.94, −0.47; 95% CI (−1.69 to −0.18, −0.71 to −0.22); I(2) = 81%, 0; GRADE: very low, moderate; BDI at six months: SMD = −0.45; 95% CI (−0.73 to −0.17); I(2) = 0; GRADE: moderate). There was no statistically significant effect for the TPC and BDI at the remaining time points (TPC at six months: SMD = −0.89; 95% CI (−1.85 to 0.07); I(2) = 91%; GRADE: very low; BDI at two weeks and three months: SMD = −0.35, −0.23; 95% CI (−0.73 to 0.04, −0.64 to 0.17); I(2) = 24%, 60%; GRADE: moderate, low). (4) Conclusions: Very low to moderate evidence indicates that BT can benefit FMS in pain and quality-of-life improvement, whereas tenderness and depression improvement varies at time phases. Established BT regimens with a large sample size and longer observation are needed. MDPI 2021-04-03 /pmc/articles/PMC8038322/ /pubmed/33916744 http://dx.doi.org/10.3390/jcm10071493 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Cao, Chun-Feng
Ma, Kun-Long
Li, Qian-Lu
Luan, Fu-Jun
Wang, Qun-Bo
Zhang, Ming-Hua
Viswanath, Omar
Myrcik, Dariusz
Varrassi, Giustino
Wang, Hai-Qiang
Balneotherapy for Fibromyalgia Syndrome: A Systematic Review and Meta-Analysis
title Balneotherapy for Fibromyalgia Syndrome: A Systematic Review and Meta-Analysis
title_full Balneotherapy for Fibromyalgia Syndrome: A Systematic Review and Meta-Analysis
title_fullStr Balneotherapy for Fibromyalgia Syndrome: A Systematic Review and Meta-Analysis
title_full_unstemmed Balneotherapy for Fibromyalgia Syndrome: A Systematic Review and Meta-Analysis
title_short Balneotherapy for Fibromyalgia Syndrome: A Systematic Review and Meta-Analysis
title_sort balneotherapy for fibromyalgia syndrome: a systematic review and meta-analysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038322/
https://www.ncbi.nlm.nih.gov/pubmed/33916744
http://dx.doi.org/10.3390/jcm10071493
work_keys_str_mv AT caochunfeng balneotherapyforfibromyalgiasyndromeasystematicreviewandmetaanalysis
AT makunlong balneotherapyforfibromyalgiasyndromeasystematicreviewandmetaanalysis
AT liqianlu balneotherapyforfibromyalgiasyndromeasystematicreviewandmetaanalysis
AT luanfujun balneotherapyforfibromyalgiasyndromeasystematicreviewandmetaanalysis
AT wangqunbo balneotherapyforfibromyalgiasyndromeasystematicreviewandmetaanalysis
AT zhangminghua balneotherapyforfibromyalgiasyndromeasystematicreviewandmetaanalysis
AT viswanathomar balneotherapyforfibromyalgiasyndromeasystematicreviewandmetaanalysis
AT myrcikdariusz balneotherapyforfibromyalgiasyndromeasystematicreviewandmetaanalysis
AT varrassigiustino balneotherapyforfibromyalgiasyndromeasystematicreviewandmetaanalysis
AT wanghaiqiang balneotherapyforfibromyalgiasyndromeasystematicreviewandmetaanalysis